Lv4
740 积分 2024-04-24 加入
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
3个月前
已完结
Wnt family members regulating osteogenesis and their origins
3个月前
已完结
Role of the Ror family receptors in Wnt5a signaling
3个月前
已完结
Unlocking the potential: advancements and future horizons in ROR1-targeted cancer therapies
3个月前
已完结
Chimeric antigen-receptor T-cell therapy for hematological malignancies and solid tumors: Clinical data to date, current limitations and perspectives
7个月前
已完结
Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b–2 study
7个月前
已完结
Morphologic Characteristics of Myelodysplastic Syndromes
7个月前
已完结
Relapsed/Refractory T- Acute Lymphoblastic Leukemia — Current Options and Future Directions
7个月前
已完结
Developing Targeted Therapies for T Cell Acute Lymphoblastic Leukemia/Lymphoma
7个月前
已完结
Genomic landscape of microsatellite instability in Chinese tumors: A comparison of Chinese and TCGA cohorts
8个月前
已完结
皖公网安备34019202002308
